11 insiders reported 73 Form 4 transactions for Aurinia Pharmaceuticals Inc. (AUPH) over the past 18 months (most recent 2026-06-02). Recent activity: TANG KEVIN (Chief Executive Officer) Buy 2,299 shares, TANG KEVIN (Chief Executive Officer) Buy 262,682 shares, TANG CAPITAL MANAGEMENT LLC (Insider) Buy 262,682 shares, TANG KEVIN (Chief Executive Officer) Buy 343,521 shares, TANG CAPITAL MANAGEMENT LLC (Insider) Buy 343,521 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-02 | TANG KEVIN | Chief Executive Officer | Buy | 2,299 | $35,290 |
| 2026-06-02 | TANG KEVIN | Chief Executive Officer | Buy | 262,682 | $4.0M |
| 2026-06-02 | TANG CAPITAL MANAGEMENT LLC | Insider | Buy | 262,682 | $4.0M |
| 2026-06-02 | TANG KEVIN | Chief Executive Officer | Buy | 343,521 | $5.2M |
| 2026-06-02 | TANG CAPITAL MANAGEMENT LLC | Insider | Buy | 343,521 | $5.2M |
| 2026-06-02 | TANG KEVIN | Chief Executive Officer | Buy | 99 | $1,519 |
| 2026-06-02 | TANG CAPITAL MANAGEMENT LLC | Insider | Buy | 99 | $1,519 |
| 2026-06-02 | TANG KEVIN | Chief Executive Officer | Buy | 206,005 | $3.1M |
| 2026-06-02 | TANG CAPITAL MANAGEMENT LLC | Insider | Buy | 206,005 | $3.1M |
| 2026-06-02 | TANG CAPITAL MANAGEMENT LLC | Insider | Buy | 2,299 | $35,290 |
| 2026-05-20 | Hearne Michael S | Chief Financial Officer | Buy | 116,144 | $0 |
| 2026-05-20 | Robertson Stephen P. | Chief Legal Officer | Buy | 115,541 | $0 |
| 2026-05-20 | Cole Ryan | Chief Operating Officer | Buy | 116,144 | $0 |
| 2026-03-10 | Keenan Greg | SVP, Chief Medical Officer | Sell | 8,069 | $115,548 |
| 2026-03-03 | TANG KEVIN | Director | Buy | 300,000 | $4.2M |
| 2026-03-03 | Miller Joseph M | Chief Financial Officer | Sell | 37,511 | $533,031 |
| 2026-03-03 | Donley Matthew Maxwell | Chief Operating Officer | Buy | 58,160 | $0 |
| 2026-03-03 | Donley Matthew Maxwell | Chief Operating Officer | Sell | 40,761 | $579,214 |
| 2026-03-03 | Greenleaf Peter | Chief Executive Officer | Buy | 196,403 | $0 |
| 2026-03-03 | Greenleaf Peter | Chief Executive Officer | Sell | 100,890 | $1.4M |
| 2026-03-03 | Robertson Stephen P. | EVP, General Counsel | Buy | 59,090 | $0 |
| 2026-03-03 | Robertson Stephen P. | EVP, General Counsel | Sell | 36,525 | $519,020 |
| 2026-03-03 | Keenan Greg | SVP, Chief Medical Officer | Buy | 40,586 | $0 |
| 2026-03-03 | Miller Joseph M | Chief Financial Officer | Buy | 57,229 | $0 |
| 2026-03-03 | TANG KEVIN | Director | Buy | 214,839 | $3.0M |
Source: SEC Form 4 filings · as of 2026-06-02